Mrinal Gounder

Associate Professor of Medicine

Medicine

Mrinal Gounder serves as Associate Professor at Cornell University.

598 publications

21,213 citations

51 h-index

Medicine

Rising Papers (1)

2025-01-06 · Nature Communications · Molecular Biology

MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial

Mrinal M. GounderAssociate Professor of Medicine · Medicine

41 citations · 15.9x expected for field

Recent Papers (14)

2026-06-01 · Cancer Medicine · Oncology

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials

Mrinal M. GounderAssociate Professor of Medicine · Medicine

Sandra P. D'AngeloAssociate Professor of Medicine · Medicine

2026-05-28 · Journal of Clinical Oncology · Gastroenterology

Phase 1a/1b study of the safety, pharmacokinetics, and antitumor activity of ziftomenib in combination with imatinib in patients with advanced gastrointestinal stromal tumors (GIST) after imatinib failure.

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2026-05-01 · Journal for ImmunoTherapy of Cancer · Pulmonary and Respiratory Medicine

Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma

Mrinal M. GounderAssociate Professor of Medicine · Medicine

Sandra D'AngeloAssociate Professor of Medicine · Medicine

2026-03-25 · Nature Communications · Molecular Biology

Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2026-03-01 · ESMO rare cancers. · Rheumatology

203P Efficacy of nirogacestat in improving sleep outcomes in adults with desmoid tumors: Post hoc analysis from the DeFi trial

2026-03-01 · ESMO rare cancers. · Rheumatology

124P Efficacy of nirogacestat in improving emotional impact outcomes in adults with desmoid tumors: Post hoc analysis from the DeFi Trial

2026-02-26 · JCO oncology advances. · Pulmonary and Respiratory Medicine

Systemic Therapy Outcomes for Soft Tissue Leiomyosarcoma Patients in an Era of Next-Generation Sequencing

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2026-02-12 · Clinical Cancer Research · Oncology

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2025-12-01 · Cancer Research Communications · Pulmonary and Respiratory Medicine

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2025-12-01 · ESMO rare cancers.

IMPACT OF PRIOR SYSTEMIC THERAPY ON TAZEMETOSTAT EFFICACY IN ADVANCED EPITHELIOID SARCOMA: POST HOC ANALYSIS OF STUDY EZH-202

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2025-12-01 · ESMO rare cancers.

ASSOCIATION OF CLINICO-PATHOLOGIC FEATURES AND MOLECULAR GENOTYPES WITH OUTCOMES OF SYSTEMIC THERAPY IN METASTATIC SOFT TISSUE LEIOMYOSARCOMA (LMS) PATIENTS

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2025-12-01 · ESMO rare cancers.

SAFETY AND EARLY EFFICACY OF VT3989, A TEAD INHIBITOR, IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): A PHASE I/II STUDY

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2025-10-20 · Journal of Clinical Oncology · Rheumatology

Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial

Mrinal M. GounderAssociate Professor of Medicine · Medicine

2025-09-29 · Journal of Onco-Nephrology · Rheumatology

Gamma-secretase inhibitor-associated hypophosphatemia in patients with desmoid tumor

Mrinal M. GounderAssociate Professor of Medicine · Medicine